Investor Presentation on Q2FY27 Financial Results

04th November, 2026 The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Plot No.C/1, Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra (East), Mumbai – 400 051. Scrip Code : 530999 Symbol : BALAMINES Dear Sir/Madam, Sub.: Investor Presentation on Q2 FY27 Financial Results Ref.: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor Presentation on Q2 FY27 Financial Results. This Investor Presentation may also be accessed on the website of the Company at https://www.balajiamines.com/investor-relations.php. This is for your kind information and records. Thanking you, Yours faithfully, For Balaji Amines Limited Abhijeet Kothadiya Company Secretary & Compliance Officer Encl.: a/a INDIA FIRST. Building What India Needs Before India Asks for It. BALAJI AMINES LIMITED Investor Presentation | Q2 & H1 FY27 Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness. FINANCIAL HIGHLIGHTS Q2 & H1 FY27 Key Highlights of the Quarter Q2 FY27 reflected resilient execution and steady progress on our strategic priorities. On a consolidated basis, Total Revenue grew 36% year-on-year to ₹472 crore, EBITDA rose 58% to ₹106 crore with a margin of 22%, and PAT increased 82% to ₹67 crore. For H1 FY27, consolidated PAT nearly doubled to ₹146 crore. Volumes were dented by external factors, including raw material availability and delayed supply chains, yet our stable product portfolio kept the top line resilient, with standalone volumes improving 11% over Q1. Commercial production commenced at our upgraded Acetonitrile facility, and with PESO approval of DME road tanker valves, we are now building our DME customer network. N-Methyl Morpholine is our next product for commercialisation, while BSCL's Unit-I brownfield expansion is on track for commissioning by end-FY27 and the Unit-II HCN, NaCN and EDTA project is targeted for Q4 FY27. With a visible expansion roadmap and Mr. Dundurapu Ram Reddy disciplined execution, we remain confident of driving sustainable growth and long-term shareholder value. Managing Director Financial highlights – Q2 FY27 STANDALONE CONSOLIDATED Total Revenue (INR Cr) EBITDA (INR Cr) Total Revenue (INR Cr) EBITDA (INR Cr) 110 461 472 429 434 103 348 106 Q2 FY26 Q1FY27 Q2 FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 PAT (INR Cr) PAT (INR Cr) EBITDA & PAT MARGIN (%) EBITDA & PAT MARGIN (%) 26% 24% 78 26% 17% 17% 31 37 11% Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 Q2FY26 Q1FY27 Q2FY27 EBITDA PAT EBITDA PAT Financial highlights – H1 FY27 STANDALONE CONSOLIDATED Total Revenue (INR Cr) EBITDA (INR Cr) Total Revenue (INR Cr) EBITDA (INR Cr) 933 227 863 213 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 PAT (INR Cr) PAT (INR Cr) EBITDA & PAT MARGIN (%) EBITDA & PAT MARGIN (%) 25% 24% 16% 16% 11% 74 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 H1 FY26 H1 FY27 EBITDA PAT EBITDA PAT Standalone Statement of Profit & Loss Particulars (Rs.Crs.) Q2FY27 Q2FY26 Y-o-Y Q1FY27 Q-o-Q H1 FY27 H1 FY26 Total Revenue 434 316 37.33% 429 1.24% 863 643 Total Raw Material 239 177 237 476 357 Employee Expenses 24 18 24 48 37 Other Expenses 68 65 58 126 128 EBITDA 103 57 81.39% 110 -5.71% 213 121 EBITDA Margin (%) 24% 18% 26% 25% 19% Depreciation 13 12 12 24 23 EBIT 91 45 99.40% 98 -7.58% 189 98 EBIT Margin (%) 21% 14% 23% 22% 15% Finance Cost 0 0 0 0 1 Profit before Tax 90 45 100.83% 98 -7.55% 188 97 Profit before Tax(%) 21% 14% 23% 22% 15% Tax 22 14 26 47 26 Profit After Tax 69 31 118.55% 72 -4.73% 141 71 PAT Margin (%) 16% 10% 17% 16% 11% EPS (As per Profit after Tax) 21.21 9.71 22.27 43.48 21.99 Consolidated Statement of Profit & Loss Particulars (Rs.Crs.) Q2FY27 Q2FY26 Y-o-Y Q1FY27 Q-o-Q H1 FY27 H1 FY26 Total Revenue 472 348 35.78% 461 2.28% 933 715 Total Raw Material 265 185 253 518 397 Employee Expenses 26 19 26 52 40 Other Expenses 75 76 61 136 147 EBITDA 106 67 58.46% 121 -12.72% 227 131 EBITDA Margin (%) 22% 19% 26% 24% 18% Depreciation 15 14 14 29 28 EBIT 91 53 72.36% 108 -15.77% 198 102 EBIT Margin (%) 19% 15% 23% 21% 14% Finance Cost 1 1 1 3 2 Profit before Tax 89 52 72.96% 106 -15.92% 196 101 Profit before Tax(%) 19% 15% 23% 21% 14% Tax 22 15 28 50 27 Profit After Tax 67 37 81.85% 78 -13.63% 146 74 PAT Margin (%) 14% 11% 17% 16% 10% EPS (As per Profit after Tax) 20.76 10.67 23.13 43.89 22.39 Consolidated Balance Sheet Statement ASSETS (Rs. Crs.) Sep-26 Mar-26 EQUITY AND LIABILITIES (Rs. Crs.) Sep-26 Mar-26 EQUITY (1) NON-CURRENT ASSETS (a) Equity Share capital 6 6 (a) Property, plant & equipment 1,160 1,035 (b) Other equity 2,077 1,970 (b) Capital work-in-progress 513 512 Attributable to owner of parent 2,083 1,976 (c) Other Intangible assets 3 3 Non controlling interest 179 175 (d) Intangible asset under development 0 0 Sub Total (C) 2,262 2,152 (e) Investment Property 4 5 LIABILITIES (f) Right-of-use assets 0 0 (1) Non-Current Liabilities (a) Financial Liabilities (g) Financial Assets (i) Lease Liabilities 0 0 (i) Investments 0 0 (i [Showing first 8,000 characters — download PDF for full document]